Figure 1. Schematic of the study. The 88 patients enrolled in this study were divided into a short androgen deprivation therapy (ADT) group (<3 years; n=47) and a continuous ADT group (>5 years; n=41). The short ADT group received ADT treatment for an average of 25.4±8.2 months.